CN1114875A - "Interleukin" specific skin-nursing product - Google Patents
"Interleukin" specific skin-nursing product Download PDFInfo
- Publication number
- CN1114875A CN1114875A CN 94111383 CN94111383A CN1114875A CN 1114875 A CN1114875 A CN 1114875A CN 94111383 CN94111383 CN 94111383 CN 94111383 A CN94111383 A CN 94111383A CN 1114875 A CN1114875 A CN 1114875A
- Authority
- CN
- China
- Prior art keywords
- interleukin
- deionized water
- liquid
- acid
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The skin-protecting cosmetic for removing freckle and spots is mainly made of interleukin, fish liver oil, phosphatide, thioglycollic acid, ammonia water, H2O2, salicylic acid, benzoic acid, potassium bromate, etc.
Description
The invention belongs to toiletries, is a kind of " interleukin " specific skin-nursing product specifically.
As everyone knows, freckle, chloasma, butterfly spot are a kind of common skin diseases, liver, kidney, endocrine and gynecological's function of it and human body are closely related, with environment such as extraneous Exposure to Sunlight, dust certain relation are arranged also simultaneously, belong to the medical and beauty treatment disease of common refractory.Prior art generally adopts Western medicine for oral administration, Chinese medicine, and the external chemistry strips off method, pour mask, smears Chinese medicine powder etc., and effect is not fairly obvious.
The objective of the invention is to avoid above-mentioned weak point of the prior art and provide a kind of freckle effect outstanding, suppress dermal melanin, make its not regrowth, can realize biological beauty cosmetics---the " interleukin " specific skin-nursing product that skin physiology brightens simultaneously.
Purpose of the present invention can reach by following measure:
At first, by cod-liver oil, Ovum Gallus domesticus album, soybean phospholipid protection skin, the massage softening skin promotes cutaneous circulation, suppresses melanin simultaneously.Re-using thioglycolic acid, the blended whitening lotion of ammonia carries out physiological and changes white.Then, cloudy disconnected with hydrogen peroxide, salicylic acid mixed liquor speckle dispelling
The propylhomoserin enzyme.Use conditioning liquid and the acid-base scale of skin of biological shrinkage water balance at last.Allow the patient adhere to cooperating, thereby reach the purpose of treatment freckle, chloasma, butterfly spot with II, III Brassin cream for face-beauty.
Composition of the present invention comprises:
1, basal liquid: cod-liver oil 500ml
2, protein liquid: 1 of fresh Ovum Gallus domesticus album
3, biological activity massage cream:
Interleukin-11 g
Semen setariae oil 300ml
Phosphatidase 12 00ml
4, whitening lotion
Thioglycolic acid 30ml
Ammonia 35ml
Deionized water 435ml
PH 8
5,5A speckle dispelling liquid:
Hydrogen peroxide 50ml
Deionized water 450ml
5B speckle dispelling crystal:
Interleukin-15 g
Salicylic acid 25g
Benzoic acid 20g
6, conditioning liquid
Vimicon 10g
Deionized water 400ml
7, shrinkage water
Potassium bromate. 15ml
Deionized water 480ml
8, II, III Brassin cream for face-beauty
The present invention has following advantage compared to existing technology:
The present invention combines hospital, beauty parlor, medical and beauty treatment and patient's self-beauty, it is outstanding to have freckle effect, suppresses dermal melanin, makes its not regrowth, simultaneously can realize that skin physiology brightens, be a kind of curative effect-type cosmetics of dispeling freckle, chloasma, butterfly spot that are exclusively used in.
Embodiment:
1, basal liquid is selected the encapsulation of pharmaceutical grade cod-liver oil filling bottle for use.
2, protein liquid by hospital, beauty parlor with fresh Ovum Gallus domesticus album autogamy.
3, biological massage cream is ground into pulp shape filling bottle with interleukin, Semen setariae oil and phospholipid.
4, whitening lotion is slowly composite, and to transfer to pH value be 8.
5,5A, 5B are composite.
6, conditioning liquid is composite.
7, shrinkage water is composite.
8, II, III Brassin cream for face-beauty interleukin and clean skin substrate are composite, and filling a prescription is every bottle of 20g, interleukin-22 g wherein, clean skin substrate 18g.
Claims (1)
1, a kind of " interleukin " specific skin-nursing product is characterized in that the present invention is made up of following eight parts:
A, basal liquid: cod-liver oil;
B, protein liquid: Ovum Gallus domesticus album;
C, biological activity massage cream: interleukin, Semen setariae oil, phospholipid;
D, whitening lotion: thioglycolic acid, ammonia, deionized water;
E, 5A speckle dispelling liquid: hydrogen peroxide, deionized water;
5B speckle dispelling crystal: interleukin, salicylic acid, benzoic acid;
F, conditioning liquid: Vimicon, deionized water;
G, shrinkage water, Potassium bromate., deionized water;
H, II, III Brassin cream for face-beauty.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94111383 CN1114875A (en) | 1994-07-11 | 1994-07-11 | "Interleukin" specific skin-nursing product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94111383 CN1114875A (en) | 1994-07-11 | 1994-07-11 | "Interleukin" specific skin-nursing product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1114875A true CN1114875A (en) | 1996-01-17 |
Family
ID=5035261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 94111383 Pending CN1114875A (en) | 1994-07-11 | 1994-07-11 | "Interleukin" specific skin-nursing product |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1114875A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101172091B (en) * | 2007-09-25 | 2011-04-27 | 北京美福源生物医药科技有限公司 | Technique for preparing amalgamation protein skin-protection product containing albuminar and skin cell growth factor, and uses of the same |
| CN102641217A (en) * | 2012-05-07 | 2012-08-22 | 广州市恺泰生物科技有限公司 | Application of interleukin-12 in facial beautifiers |
| CN107412488A (en) * | 2017-08-09 | 2017-12-01 | 姬兴祥 | A kind of Chinese medicine reduction nti-freckle breast and preparation method thereof |
| CN118001176A (en) * | 2024-04-09 | 2024-05-10 | 山东泉港药业有限公司 | Application of recombinant human interleukin 2 (I) |
-
1994
- 1994-07-11 CN CN 94111383 patent/CN1114875A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101172091B (en) * | 2007-09-25 | 2011-04-27 | 北京美福源生物医药科技有限公司 | Technique for preparing amalgamation protein skin-protection product containing albuminar and skin cell growth factor, and uses of the same |
| CN102641217A (en) * | 2012-05-07 | 2012-08-22 | 广州市恺泰生物科技有限公司 | Application of interleukin-12 in facial beautifiers |
| CN107412488A (en) * | 2017-08-09 | 2017-12-01 | 姬兴祥 | A kind of Chinese medicine reduction nti-freckle breast and preparation method thereof |
| CN118001176A (en) * | 2024-04-09 | 2024-05-10 | 山东泉港药业有限公司 | Application of recombinant human interleukin 2 (I) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pearson et al. | Epidermolysis bullosa hereditaria letalis: Clinical and histological manifestations and course of the disease | |
| US7604821B2 (en) | Porifera-based therapeutic compositions for treating and preventing skin diseases | |
| CN1547475B (en) | Dermal therapy using phosphate derivatives of electron transfer agents | |
| Onwukwe et al. | Hereditary papulotranslucent acrokeratoderma: a new variant of familial punctate keratoderma? | |
| CN106389139A (en) | Acne-removing, mark-eliminating and skin-protecting multifunctional preparation and preparation method thereof | |
| EP1482966B1 (en) | Method and composition for treating skin wounds with epidermal growth factor | |
| KR102452905B1 (en) | the method for skin improvement cosmetic composition containing natural spicule and polydioxanone and the cosmetic composition thereof | |
| CN1114875A (en) | "Interleukin" specific skin-nursing product | |
| JPS63185925A (en) | 13-cis-retinoic acid-containing drug | |
| KR20150119244A (en) | Topical composition for stimulating epidermis and dermis layers of the skin | |
| US4801444A (en) | Medicinal preparation for individual prevention of venereal diseases and treatment of urogenital trichomoniasis | |
| CN106563121B (en) | BFGF bovine basic fibroblast growth factor gel is repairing the application in acne rosacea skin lesion | |
| Jones et al. | The use and role of zinc and its compounds in wound healing | |
| Murgia et al. | New Enzymatic Gel as Adjuvant Treatment for Wound Healing Processes in Oral Surgery, a Mini-Review and a Case Report | |
| TOMPKINS et al. | Lipoid proteinosis: two case reports including liver biopsies, special blood lipid analyses, and treatment with a lipotropic agent | |
| CN110624102A (en) | Clinical application of bevacizine as medicine for repairing demodex disease skin damage | |
| CN1738594A (en) | Use of a composition comprising vitamin K1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions | |
| Bensignor et al. | Morphea‐like lesion in a cat | |
| JPH10120561A (en) | Skin preparation for improving sputum for external use | |
| Orpin et al. | The ‘St. Tropez’sign; a new dermoscopic feature of seborrhoeic keratoses? | |
| KR20070006626A (en) | Topical composition for transdermal administration | |
| Kellum | Intralesional injection of sodium stibogluconate by dermal pressure-jet instrument | |
| CN2192270Y (en) | Healthy cosmetic wet tissues | |
| Driver et al. | CENTRAL STATES DERMATOLOGICAL SOCIETY: Meeting Held Under the Auspices of the Cleveland Dermatological Society | |
| CN117084945A (en) | Lavender compound acne-removing preparation and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |